The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Nobilis Rismavac + CA126

Intervet Ireland LimitedVPA10996/086/001

Main Information

Trade NameNobilis Rismavac + CA126
Active SubstancesLive chicken herpes virus strain CVI-988
Live turkey herpes virus strain FC126
Dosage FormConcentrate for solution for injection
Licence HolderIntervet Ireland Limited
License Holder AddressMagna Drive
Magna Business Park, Citywest Road
Dublin 24
Licence NumberVPA10996/086/001

Group Information

ATC CodeQI01AD03 avian herpes virus (marek's disease)
Therapeutic ClassImmunological - Live Vaccine


License statusWithdrawn
Withdrawn Date01/09/2023
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back